The intestinal flora in the human body is made up of billions of microorganisms: bacteria, yeasts, fungi and even viruses. This flora, also called microbiota, is characterised by a subtle balance between these different microorganisms. An imbalance can lead to feelings of discomfort, including in the intestines.
Saccharomyces cerevisiae is a non-colonising yeast. This means that it does not adhere to the intestinal wall, limiting the risk of candidiasis. However, it can reach a high concentration in the intestine and remain there in a living form. Numerous studies1-3 have been carried out with Saccharomyces cerevisiae CNCM I-3856.
This includes, for example, the randomised double-blind, placebo-controlled clinical study of Pineton de Chambrun1, which was conducted on people aged 18 to 75 years with signs of irritable bowel syndrome1.
Cerevisia contains a specific strain of yeast: Saccharomyces cerevisiae CNCM I-3856: This strain was selected from more than 6,000 yeast strains after years of research.
The specific strain used in Cerevisia is registered with the CNCM (Collection Nationale de Cultures de Microorganismes).
Saccharomyces cerevisiae CNCM I-3856: 4 billion good yeast
* Maximum recommended daily dose.
1 capsule of Cerevisia per day to be taken in the morning with a meal.
To prolong the effects of Saccharomyces cerevisiae CNCM I-3856, it is advisable to continue taking Cerevisia over time.
Food supplement • AS 21/31
FOOD SUPPLEMENT - Do not exceed the recommended daily dose. Not a substitute for a balanced and varied diet and a healthy lifestyle. Prolonged use of live microorganisms in children, immunocompromised adults and patients with central venous catheters is not recommended.
1Pineton de Chambrun et al, 2015
2Spiller R. et al, 2015
3Cayzelle-Decherf A. et al, 2017
Imutis aids the functioning of the immune system*.
No result was found for your search